Wells Fargo Maintains Overweight on Eli Lilly, Raises Price Target to $1330

Benzinga · 2d ago
Wells Fargo analyst Mohit Bansal maintains Eli Lilly (NYSE:LLY) with a Overweight and raises the price target from $1280 to $1330.